"4.9. P\u0159ed\u00E1vkov\u00E1n\u00ED "@cs . . "Sou\u010Dasn\u00E9 zku\u0161enosti s p\u0159ed\u00E1vkov\u00E1n\u00EDm mirtazapinem ukazuj\u00ED, \u017Ee symptomy jsou obvykle m\u00EDrn\u00E9. Byl pops\u00E1n \u00FAtlum centr\u00E1ln\u00EDho nervov\u00E9ho syst\u00E9mu se zmatenost\u00ED a prodlou\u017Eenou sedac\u00ED, spolu s tachykardi\u00ED a m\u00EDrnou hypertenz\u00ED nebo hypotenz\u00ED. Je zde ale mo\u017Enost velmi z\u00E1va\u017En\u00FDch dopad\u016F (v\u010Detn\u011B fat\u00E1ln\u00EDch) p\u0159i mnohem vy\u0161\u0161\u00EDm d\u00E1vkov\u00E1n\u00ED ne\u017E je terapeutick\u00E1 d\u00E1vka, obzvl\u00E1\u0161t\u011B jde-li o sm\u00ED\u0161en\u00E9 p\u0159ed\u00E1vkov\u00E1n\u00ED.\nPacienti s p\u0159ed\u00E1vkov\u00E1n\u00EDm\u00A0by pro udr\u017Een\u00ED vit\u00E1ln\u00EDch funkc\u00ED m\u011Bli dostat p\u0159\u00EDslu\u0161nou symptomatickou a podp\u016Frnou l\u00E9\u010Dbu. Doporu\u010Duje se zv\u00E1\u017Eit tak\u00E9 pod\u00E1n\u00ED \u017Eivo\u010Di\u0161n\u00E9ho uhl\u00ED nebo v\u00FDplach \u017Ealudku.\n \n \n"@cs . . . "004.009" .